Amicus Therapeutics Inc (FOLD)
9.21
-0.26
(-2.75%)
USD |
NASDAQ |
May 10, 11:09
Amicus Therapeutics Debt to Equity Ratio: 2.422 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.422 |
| September 30, 2023 | 2.958 |
| June 30, 2023 | 3.525 |
| March 31, 2023 | 3.828 |
| December 31, 2022 | 3.186 |
| September 30, 2022 | 2.952 |
| June 30, 2022 | 2.253 |
| March 31, 2022 | 1.634 |
| December 31, 2021 | 1.267 |
| September 30, 2021 | 1.032 |
| June 30, 2021 | 1.825 |
| March 31, 2021 | 1.554 |
| December 31, 2020 | 1.359 |
| September 30, 2020 | 1.213 |
| June 30, 2020 | 0.4157 |
| March 31, 2020 | 0.3719 |
| December 31, 2019 | 0.3138 |
| September 30, 2019 | 0.2722 |
| June 30, 2019 | 0.2484 |
| March 31, 2019 | 0.3738 |
| December 31, 2018 | 0.9383 |
| September 30, 2018 | 0.7758 |
| June 30, 2018 | 0.3016 |
| March 31, 2018 | 0.3197 |
| December 31, 2017 | 0.4653 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.3945 |
| June 30, 2017 | 0.5964 |
| March 31, 2017 | 0.5047 |
| December 31, 2016 | 0.4289 |
| September 30, 2016 | 0.1962 |
| June 30, 2016 | 0.1953 |
| March 31, 2016 | 0.1236 |
| December 31, 2015 | 0.1196 |
| September 30, 2015 | 0.132 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.1384 |
| December 31, 2014 | 0.1175 |
| September 30, 2014 | 0.3305 |
| June 30, 2014 | 0.3954 |
| March 31, 2014 | 0.4637 |
| December 31, 2013 | 0.3163 |
| September 30, 2013 | 0.015 |
| June 30, 2013 | 0.0126 |
| March 31, 2013 | 0.0112 |
| December 31, 2012 | 0.0101 |
| September 30, 2012 | 0.0117 |
| June 30, 2012 | 0.018 |
| March 31, 2012 | 0.0214 |
| December 31, 2011 | 0.0353 |
| September 30, 2011 | 0.0369 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2484
Minimum
Jun 2019
3.828
Maximum
Mar 2023
1.717
Average
1.554
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| TG Therapeutics Inc | 0.6329 |
| Geron Corp | 0.2399 |
| Vanda Pharmaceuticals Inc | 0.00 |
| Fate Therapeutics Inc | 0.00 |
| Editas Medicine Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 777.88M |
| Total Liabilities (Quarterly) | 617.71M |
| Shareholders Equity (Quarterly) | 160.17M |
| Current Ratio | 2.881 |
| Net Debt Paydown Yield | 0.02% |